Skip to main content
. Author manuscript; available in PMC: 2022 Jan 3.
Published in final edited form as: AAPS PharmSciTech. 2021 Jan 3;22(1):18. doi: 10.1208/s12249-020-01892-w

Table I.

Experimental Design to Determine the Effect of Factors on the Transfection Efficiency of Luc-MVs and Luc-EXOs

Factors Level 1 Level 2 Level 3
Amount of Luc pDNA (μg/well)a 0 0.5 1
Total EV protein (μg)b 6 N/A 12
Type of EVs EXOs N/A MVs
Incubation time (h)c 24 48 72
a

Amount of Luc pDNA represents the amount of gWiz-Luc pDNA transfected into the donor cells using lipofectamine3000 in each well in a 24-well plate and the EVs were isolated from a single 24-well plate that was transfected with a total of either 0, 12, or 24μg pDNA.

b

Total EV protein represents the protein content in EXOs or MVs quantified by MicroBCA protein assay

c

Incubation time represents the time that recipient hCMEC/D3 cells were treated using Luc-EVs. N/A: not applicable